METTL3 and steatosis: In contrast, our recent study demonstrated that the deletion of Alkbh5 (the gene encoding ALKBH5, an m6A eraser protein) in the liver enhances glucose and lipid homeostasis while maintaining normal liver function.[32] Additionally, targeted inhibition of hepatic ALKBH5 prevents HFD‐induced liver injury and steatosis,[32] offering an alternative therapeutic approach.